Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 1;5(1):173-7.
doi: 10.1177/193229681100500124.

Blood glucose testing in the hospital: error sources and risk management

Affiliations
Review

Blood glucose testing in the hospital: error sources and risk management

James H Nichols. J Diabetes Sci Technol. .

Abstract

Glucose testing in the hospital with point-of-care devices presents multiple opportunities for error. Any device can fail under the right conditions. For glucose monitoring in the hospital, with thousands of operators, hundreds of devices, and dozens of locations involved, there is ample opportunity for errors that can impact the quality of test results. Errors can occur in any phase of the testing process: preanalytic, analytic, or postanalytic. Common sources of meter error include patient or methodology interferences, operator mistakes, environmental exposure, and device malfunction. Early models of glucose meters had few internal checks or capability to warn the operator of meter problems. The latest generation of glucose monitors has a number of internal checks and controls engineered into the testing process to prevent serious errors or warn the operator by suppressing test results. Some of these control processes are built into the software and data management system of the meters, others require the hospital to do something, such as regularly clean the meter or analyze control samples of known glucose concentration, to verify meter performance. Hospitals need to be aware of the potential for errors by understanding weaknesses in the testing process that could lead to erroneous results and take steps to prevent errors from occurring or to minimize the harm to patients when errors do occur. The reliability of a glucose result will depend on the balance of internal control features available from manufacturers in conjunction with the liquid control analysis and other control processes (operator training, device validation, and maintenance) utilized by the hospitals.

PubMed Disclaimer

References

    1. International Organization for Standardization. Medical devices – application of risk management to medical devices. ISO 14971. 2nd ed. Geneva, Switzerland: IOS; 2007.
    1. Clinical and Laboratory Standards Institute. Risk management techniques to identify and control laboratory error sources; approved guideline. EP18-A2. 2nd ed. Wayne, PA: CLSI; 2009.
    1. Klonoff DC, Perz JF. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol. 2010;4(5):1027–1031. - PMC - PubMed
    1. Ginsberg BH. We need tighter regulatory standards for blood glucose monitoring, but they should be for accuracy disclosure. J Diabetes Sci Technol. 2010;4(5):1265–1268. - PMC - PubMed
    1. Medicines and Healthcare Products Regulatory Agency, U.K. Department of Health. Medical device alert. MDA/2007/058 – Point of care and home-use blood glucose meters: Roche Accu-Chek and Glucotrend; Abbott Diabetes Care FreeStyle. July 19, 2007. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mhra.gov.uk">www.mhra.gov.uk</ext-link>. Accessed August 2010.